期刊文献+

肥胖人群血清炎症因子水平与2型糖尿病发生的相关性研究 被引量:1

下载PDF
导出
摘要 目的:研究肥胖人群炎症因子水平与2型糖尿病发生的相关性。方法:检测160例肥胖人群和160例非肥胖人群血清C-反应蛋白(CRP)和纤维蛋白原(Fg)水平,并测量其身高、体重、腰围、血压,计算体重指数(BMI),测定血脂、血糖。结果:肥胖人群血浆CRP和Fg水平明显高于非肥胖人群,并与FPG、2hPG、BMI、TG、LDL-C、收缩压、舒张压呈正相关,与HDL-C呈负相关。肥胖组2型糖尿病发生率、高血压发生率显著高于非肥胖组。结论:肥胖人群已出现炎症表现,CRP和Fg在2型糖尿病的发生、发展中起着重要作用。
出处 《中国医药导报》 CAS 2008年第12期29-30,共2页 China Medical Herald
  • 相关文献

参考文献3

二级参考文献21

  • 1Schmidt MI, Duncan BB, Scharrct AR, et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet, 1999,353:1649-1652.
  • 2Barzilay JI, Abraham L, Heckbert SR, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes, 2001,50:2384-2389.
  • 3Pradhan AD, Manson JE, Rifai N, et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA, 2001,286:327-334.
  • 4Festa A, Ralph BD, Russell PT, et al. Elevated levels of acute phase proteins and plasminogen activator inhibitor-1 (PAI-1) predict the development of type 2 diabetes mellitus: the insulin resistance atherosclerosis study (IRAS). Diabetes, 2000,49(Suppl 1):A24-A25.
  • 5Duncan BB, Schmidt MI, Offenbacher S, et al. Factor Ⅷ and other hemostasis variables are related to incident diabetes in adults. Diabetes care, 1999,22:767-772.
  • 6Lindsay RS, Krakoff J, Hanson RL, et al. Gamma globulin levels predict type 2 diabetes in the Pima Indian population. Diabetes, 2001,50:1598-1603.
  • 7Mcneely MJ, Bokyko EJ, Weigle DS, et al. Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans. Diabetes Care, 1999,22:65-70.
  • 8Yuan M, Konstantopoulos N, Lee J, et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of IKKbeta. Science, 2001,293:1673-1677.
  • 9Hundal RS, Petersen KF, Mayerson AB, et al. Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J Clin Invest, 2002,109:1321-1326.
  • 10Freeman DJ, Norrie J, Sattar N, et al. Pravastatin and the development of diabetes mellitus, evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study. Circulation, 2001,103:357-362.

共引文献261

同被引文献5

  • 1牟忠卿,陈丽.糖尿病与氧化应激[J].国外医学(内分泌学分册),2005,25(6):393-395. 被引量:26
  • 2Hoeldtke RD, Bryner KD, McNeil DR, et al. Nitrosative stress, uricacid, and peripheral nelrve function in early type 1 diabetes. Diabetes 2002;51:2817 -2825.
  • 3Bitar MS, wa/lid S, Pilcher CW, et al. A1 pha-lipoic acid mit- igates insulin resistance in Goto-Kakizaki rats. Horm Metab Res 2004 ;36:542 - 549.
  • 4Da Ros R, Assaloni R, Ceriello A. The preventive anti-oxidant action Of thiazolidinediones:a new therapeutic prospect in diabetes and insulin re-sistance. Diabet Med 2004 ;21 : 1249 - 1252.
  • 5Pradhan AD, Manson JE, Rifai N, et al. C-reactive protein, in- terleukin 6, and risk of developing type 2 diabetes meUitus. JAMA 2001 ;286:327 -334.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部